First gene therapy — ‘a true living drug’ — on the cusp of FDA approval – Chicago Tribune
Chicago Tribune |
First gene therapy — ‘a true living drug’ — on the cusp of FDA approval
Chicago Tribune If cleared by the FDA, it would be the first gene therapy approved in the United States. But unlike traditional gene therapy, the new treatment doesn’t replace disease-causing genes with healthy ones. Instead, it uses technology to reprogram immune … CAR-T gene therapy for leukemia clears FDA hurdleCBS News Did an FDA Panel Really Just Approve the First Gene Therapy Treatment?Gizmodo FDA Panel OKs First Gene Therapy For LeukemiaWebMD CNBC –USA TODAY –ABC News –FDA all 245 news articles » |
Asbestos.com |
Mesothelioma Clinical Trial Combines Immunotherapy Drugs
Asbestos.com Tanvetyanon is the principal investigator of a much-anticipated phase II clinical trial involving an immunotherapy drug combination with considerable potential for extending survival. “This is exciting. We now can offer something with realistic hope … |
Asbestos.com |
Mesothelioma Clinical Trial Combines Immunotherapy Drugs
Asbestos.com Tanvetyanon is the principal investigator of a much-anticipated phase II clinical trial involving an immunotherapy drug combination with considerable potential for extending survival. “This is exciting. We now can offer something with realistic hope … |
|
Benefits of Using Droplet Digital PCR for Measuring Immunotherapy …
SelectScience New research demonstrating the clinical potential of Bio-Rad ‘s Droplet Digital PCR (ddPCR) technology to measure patient response to immunotherapy was … |
Drug Discovery & Development |
FDA Panel Recommends Approval for Novartis CAR–T Cell Therapy
Drug Discovery & Development The U.S. Food and Drug Administration’s Oncologic Drugs Advisory Committee unanimously voted to recommend approval for CTL019, an experimental cancer drug that belongs to a class of drugs called CAR T-cell therapies, which is a form of … FDA Panel Unanimously Recommends Approval for Novartis’ CAR T-Cell Therapy CTL019Genetic Engineering & Biotechnology News CAR–T gene therapy for leukemia clears FDA hurdleCBS News Novartis’ stellar CAR–T efficacy data steamrolls safety doubts to power landmark cancer therapy toward approvalFierceBiotech ABC News –Seeking Alpha –FDA –New York Times all 245 news articles » |
Fortune |
Going to the Wall Against Cancer and Apathy
Fortune It’s to prioritize immunotherapy, which uses the immune system against cancer. Ideally it can ultimately supersede chemotherapy, radiation, and most surgeries as well as recurrences and secondary cancers, such as Good Morning America’s Robin Roberts’s, … |